Lantheus Holdings, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
LNTH on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
331 Treble Cove Road, North Billerica, Massachusetts

Insiders trading volume in the past year

Lantheus Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mary Anne Heino Director $34.1M -$7.63M -18.3% May 9, 2024
Brian A. Markison CEO, Director $8.45M Mar 1, 2024
Paul Blanchfield President $8.2M -$1.44M -14.9% May 31, 2024
Robert J. Marshall Jr. CFO and Treasurer $6.82M -$2.67M -28.1% Mar 15, 2024
Daniel Niedzwiecki Chief Administrative Officer, General Counsel and Corporate Secretary $6.41M -$1.51M -19.1% May 30, 2024
Etienne Montagut Chief Business Officer $6.19M Mar 5, 2024
John J. Bolla Chief Operations Officer $5.74M Jun 16, 2021
Andrea Sabens Chief Accounting Officer $4.84M -$312K -6.07% May 13, 2024
Sam R. Leno Director $3.72M -$1.73M -31.7% May 9, 2024
Carol Walker Senior Vice President, Quality $3.63M Mar 30, 2022
Gerard Ber Director $2.86M May 9, 2024
Gary J. Pruden Director $2.84M May 20, 2024
Jean-Claude Provost Chief Medical Officer $2.54M Mar 5, 2024
Julie McHugh Director $2.25M -$196K -8.03% May 28, 2024
James H. Thrall Director $2.16M May 9, 2024
Heinz Christoph Maeusli Director $1.87M -$1.45M -43.7% May 28, 2024
Ying Vivian Yao Chief Human Resources Officer $1.7M Jan 18, 2022
Amanda Michelle Morgan Chief Commercial Officer $1.52M Mar 25, 2024
Minnie Baylor-Henry Director $452K May 9, 2024
Jeffrey Humphrey Chief Medical Officer $0 May 28, 2024

Recent Insider Transactions by Companies or Individuals for Lantheus Holdings, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership